CurrentBlue Cross Blue Shield - Rhode IslandPolicy N/A

DRAFT Medical Coverage Policy Electrical Stimulation for Treatment of Arthritis

Policy governs coverage determination for noninvasive pulsed electrical and pulsed electromagnetic stimulation devices used to treat osteoarthritis and rheumatoid arthritis for BlueCHiP for Medicare and Commercial products. It states coverage stance (not covered / not medically necessary) and provides coding guidance.

Policy Summary

PayerBlue Cross Blue Shield - Rhode Island

PolicyDRAFT Medical Coverage Policy Electrical Stimulation for Treatment of Arthritis

Policy CodePolicy N/A

Change TypeNo material change

Effective DateOct 1, 2019

Next Review Date

Key ActionDo not expect coverage—claims for electrical or electromagnetic stimulation devices (e.g., HCPCS E0762) for osteoarthritis or any other condition are not covered for BlueCHiP for Medicare and are not medically necessary for Commercial Products; expect denial or nonpayment.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes; policy has no listed changes.

1Primary HCPCS code listed as not covered

2Payer products referenced (Medicare, Commercial)

Coverage Summary

Scope: This policy governs coverage determination for noninvasive pulsed electrical and pulsed electromagnetic stimulation devices (including capacitive coupling, pulsed electromagnetic fields, combined magnetic fields) used to treat osteoarthritis and rheumatoid arthritis for BlueCHiP for Medicare and Commercial products.

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Medical Necessity / Coverage Determinations

Coverage determination

Electrical or electromagnetic stimulation for arthritis is covered only when criteria are met; policy statements list noncoverage/not medically necessary determinations:

BlueCHiP for Medicare noncoverage: Electrical stimulation for the treatment of osteoarthritis or any other condition is not covered as the evidence is insufficient to determine the effects of the technology on health outcomes.
Source: BlueCHiP for Medicare policy statement
Commercial Products not medically necessary: Electrical stimulation for the treatment of osteoarthritis or any other condition is not medically necessary as the evidence is insufficient to determine the effects of the technology on health outcomes.
Source: Commercial Products policy statement

Not Covered / Not Medically Necessary

Policy statements: For BlueCHiP for Medicare, electrical stimulation for the treatment of osteoarthritis or any other condition is not covered because the evidence is insufficient to determine the effects of the technology on health outcomes.

For Commercial Products, electrical stimulation for the treatment of osteoarthritis or any other condition is not medically necessary because the evidence is insufficient to determine the effects of the technology on health outcomes.

Coding guidance: HCPCS code E0762 (Transcutaneous electrical joint stimulation device system, includes all accessories) is listed as not covered for BlueCHiP for Medicare and not medically necessary for Commercial Products.

Benefit note: Benefits may vary by contract; refer to the applicable benefit booklet, Evidence of Coverage, or subscriber agreement for specific coverage determinations.

Noncoverage / Not medically necessary (denial logic)

Denial / Noncoverage statements

Medicare denial: BlueCHiP for Medicare: Electrical stimulation for the treatment of osteoarthritis or any other condition is not covered (evidence insufficient).
Commercial denial: Commercial Products: Electrical stimulation for the treatment of osteoarthritis or any other condition is not medically necessary (evidence insufficient).
HCPCS coding guidance: HCPCS E0762 (Transcutaneous electrical joint stimulation device system, includes all accessories) is not covered for BlueCHiP for Medicare and is not medically necessary for Commercial Products.

Provider Actions / Billing Impact

Denial Risk

Claims for electrical stimulation devices for arthritis likely denied/not payable

Claims for HCPCS E0762 for treatment of osteoarthritis or any other condition are not covered for BlueCHiP for Medicare and are not medically necessary for Commercial Products; expect denial or nonpayment.

Affected code: E0762
Applicable payer products: BlueCHiP for Medicare; Commercial Products

Background, Evidence, and Definitions

Background and evidence summary: Pulsed electrical and electromagnetic stimulation have been investigated as adjunctive treatments for osteoarthritis and rheumatoid arthritis, with devices that deliver subsensory low-voltage monophasic electrical fields or electromagnetic fields via treatment coils, capacitive coupling, or combined magnetic fields.

Regulatory history: Several devices (for example, the BioniCare Bio-1000 system, OrthoCor Active Knee System, SofPulse/Torino II, and ActiPatch) received U.S. FDA 510(k) clearance for related adjunctive/palliative indications.

Evidence assessment: Multiple randomized, placebo‑controlled trials and systematic reviews (including a Cochrane review) are cited, but the policy concludes that for individuals with arthritis who receive electrical or electromagnetic stimulation, the evidence is insufficient to determine the effects of the technology on health outcomes.

Evidence Source	Summary
Systematic review / Cochrane	Cochrane review (2013) and multiple randomized placebo-controlled trials cited; evidence judged insufficient
Policy coverage statements	For BlueCHiP for Medicare and Commercial Products, electrical stimulation for osteoarthritis or any other condition is not covered / not medically necessary because evidence is insufficient to determine effects on health outcomes.

Term	Definition
Electrical stimulation	Noninvasive device delivering subsensory low-voltage monophasic electrical field to target site of pain.
Pulsed electromagnetic fields (PEMF)	Electromagnetic fields delivered via treatment coils placed over the skin; includes capacitive coupling and combined magnetic fields.

Name	Number	Type	Effective
Transcutaneous Electrical Joint Stimulation Devices (TEJSD)	L34821	LCD

Definitions & Quick Facts

Quick facts

Electrical stimulationNoninvasive device delivering subsensory low-voltage monophasic electrical field to target site of pain.

Pulsed electromagnetic fields (PEMF)Electromagnetic fields delivered via treatment coils placed over the skin; includes capacitive coupling and combined magnetic fields.

Coding noteNo CPT code; HCPCS E0762 may be used and is listed as not covered / not medically necessary.

Coverage determinationElectrical stimulation for treatment of osteoarthritis or any other condition is not covered for BlueCHiP for Medicare and is not medically necessary for Commercial Products; evidence insufficient to determine health outcomes.

Evidence summaryCochrane review (2013) and multiple randomized placebo-controlled trials cited; evidence judged insufficient.

Revision History

2019-10-01Effective Date

Policy became effective. Electrical and electromagnetic stimulation for treatment of arthritis is discussed; evidence is considered insufficient to determine effects on health outcomes.

2019-05-21Last ReviewedLatest

Policy last reviewed; no material changes listed (has_material_change=false). Coverage statements: not covered for BlueCHiP for Medicare and not medically necessary for Commercial Products.